Associations between the expression of MTA1 and VEGF‑C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis

Liu,Jianping; Xia,Juan; Zhang,Yongheng; Fu,Maoyong; Gong,Sheng; Guo,Yulong

doi:10.3892/ol.2017.6530

Associations between the expression of MTA1 and VEGF‑C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis

Authors:
- Jianping Liu
- Juan Xia
- Yongheng Zhang
- Maoyong Fu
- Sheng Gong
- Yulong Guo
View Affiliations

Affiliations: Department of Cardiothoracic Surgery, Suining Central Hospital, Suining, Sichuan 629000, P.R. China, Department of Pathology, Suining Central Hospital, Suining, Sichuan 629000, P.R. China, Department of Cardiothoracic Surgery, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China
Published online on: July 7, 2017 https://doi.org/10.3892/ol.2017.6530
Pages: 3275-3281

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the association between the expression levels of metastasis‑related gene 1 (MTA1) and vascular endothelial growth factor C (VEGF‑C) in esophageal squamous cell carcinoma (ESCC) with lymph angiogenesis and lymph node metastasis. The paraffin‑embedded tissue samples of 107 cases of ESCC and 56 cases of normal esophageal tissues were collected from the Department of Cardiothoracic Surgery, Suining Central Hospital from March 2013 to January 2014. Immunohistochemical assays were performed to detect the expression levels of MTA1, VEGF‑C and D2‑40 in ESCC, and the micro‑lymphatic vessel density (LVD) was evaluated. Their associations with various clinicopathological parameters were also analyzed. The protein expression levels of MTA1 and VEGF‑C in ESCC were significantly higher compared with those in normal esophageal tissues (P<0.05); the high protein expression levels of MTA1 and VEGF‑C in ESCC tissues at various tumor‑node‑metastasis stages exhibited statistically significant differences, as revealed by the Kruskal‑Wallis test (P<0.05). The protein expression levels of MTA1 and VEGF‑C in ESCC exhibited positive correlations (Spearman's ρ, r=0.512; P=0.000); the LVD level in the group with high expression of MTA1 and VEGF‑C was significantly higher compared with in the low expression group (P<0.05). The comparison between MTA1 and VEGF‑C protein expression levels in the group with a high rate of lymph node metastasis demonstrated statistically significant differences when compared with in the low lymph node metastasis group (P<0.05). The expression levels of MTA1 and VEGF‑C in ESCC exhibited a positive correlation in ESCC, which may co‑promote lymph angiogenesis and lymph node metastasis in ESCC; therefore, they may be used as biomarkers for determining the prognosis of ESCC.

View Figures

View References

1	Lin CS, Cheng CT, Liu CY, Lee MY, Hsiao MC, Shih CH and Liu CC: Radical lymph node dissection in primary esophagectomy for esophageal squamous cell carcinoma. Ann Thorac Surg. 100:278–286. 2015. View Article : Google Scholar : PubMed/NCBI
2	Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Handbook. 7th. Springer; New York, NY: 2010
3	Xu XL, Zheng WH, Zhu SM, Zhao A and Mao WM: The prognostic impact of lymph node involvement in large scale operable node-positive esophageal squamous cell carcinoma patients: A 10-year experience. PLoS One. 10:e01330762015. View Article : Google Scholar : PubMed/NCBI
4	Feng Y, Wang W, Hu J, Ma J, Zhang Y and Zhang J: Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer. Anat Rec (Hoboken). 293:802–812. 2010. View Article : Google Scholar : PubMed/NCBI
5	Wakisaka N, Hirota K, Kondo S, Sawada-Kitamura S, Endo K, Murono S and Yoshizaki T: Induction of lymphangiogenesis through vascular endothelial growth factor-C/vascular endothelial growth factor receptor 3 axis and its correlation with lymph node metastasis in nasopharyngeal carcinoma. Oral Oncol. 48:703–708. 2012. View Article : Google Scholar : PubMed/NCBI
6	Pérez D, Rohde A, Callejón G, Pérez-Ruiz E, Rodrigo I, Rivas-Ruiz F, Ramos B, Medina F, Villatoro R, Redondo M, et al: Correlation between serum levels of vascular endothelial growth factor-C and sentinel lymph node status in early breast cancer. Tumour Biol. 36:9285–9293. 2015. View Article : Google Scholar : PubMed/NCBI
7	Li DQ, Suresh SB, Sujit SS, Eswaran J and Kumar R: Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer. Cancer Res. 72:387–394. 2012. View Article : Google Scholar : PubMed/NCBI
8	Li SH, Tian H, Yue WM, Li L, Li WJ, Chen ZT, Hu WS, Zhu YC and Qi L: Overexpression of metastasis-associated protein 1 is significantly correlated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Ann Surg Oncol. 18:2048–2056. 2011. View Article : Google Scholar : PubMed/NCBI
9	Kai L, Wang J, Ivanovic M, Chung YT, Laskin WB, Schulze-Hoepfner F, Mirochnik Y, Satcher RL Jr and Levenson AS: Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1). Prostate. 71:268–280. 2011. View Article : Google Scholar : PubMed/NCBI
10	Prisco MG, Zannoni GF, De Stefano I, Vellone VG, Tortorella L, Fagotti A, Mereu L, Scambia G and Gallo D: Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: A clinical study. Hum Pathol. 43:282–288. 2012. View Article : Google Scholar : PubMed/NCBI
11	Nagaraj SR, Shilpa P, Rachaiah K and Salimath BP: Crosstalk between VEGF and MTA1 signaling pathway to aggressiveness of breast carcinoma. Mol Carcinog. 54:333–350. 2015. View Article : Google Scholar : PubMed/NCBI
12	Hofer MD, Kuefer R, Varambally S, Li H, Ma J, Shapiro GI, Gschwend JE, Hautmann RE, Sanda MG, Giehl K, et al: The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res. 64:825–829. 2004. View Article : Google Scholar : PubMed/NCBI
13	Miyake K, Yoshizumi T, Imura S, Sugimoto K, Batmunkh E, Kanemura H, Morine Y and Shimada M: Expression of hypoxiainducible actor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: Correlation with poor prognosis with possible regulation. Pancreas. 36:e1–e9. 2008. View Article : Google Scholar : PubMed/NCBI
14	Aishima S, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y and Tsuneyoshi M: Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma. Mod Pathol. 21:256–264. 2008. View Article : Google Scholar : PubMed/NCBI
15	Sawyers CL: The cancer biomarker problem. Nature. 452:548–552. 2008. View Article : Google Scholar : PubMed/NCBI
16	Zamanian-Azodi M, Rezaei-Tavirani M, Hasanzadeh H, Rahmati Rad S and Dalilan S: Introducing biomarker panel in esophageal, gastric, and colon cancers; A proteomic approach. Gastroenterol Hepatol Bed Bench. 8:6–18. 2015.PubMed/NCBI
17	Saad RS, Lindner JL, Liu Y and Silverman JF: Lymphatic vessel density as prognostic marker in esophageal adenocarcinoma. Am J Clin Pathol. 131:92–98. 2009. View Article : Google Scholar : PubMed/NCBI
18	Straume O, Jackson DG and Akslen LA: Independent prognostic impact lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res. 9:250–256. 2003.PubMed/NCBI
19	Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, et al: Lymphatic metastasis in the absence of functional intratumor lymphatics. Science. 296:1883–1886. 2002. View Article : Google Scholar : PubMed/NCBI
20	Deng X, Du L, Wang C, Yang Y, Li J, Liu H, Zhang J, Wang L, Zhang X, Li W, et al: Close association of metastasis-associated protein 1 overexpression with increased angiogenesis and poor survival in patients with histologically node-negative gastric cancer. World J Surg. 37:792–798. 2013. View Article : Google Scholar : PubMed/NCBI
21	Xie LX, Zhai TT, Yang LP, Yang E, Zhang XH, Chen JY and Zhang H: Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma. Int J Exp Pathol. 94:39–46. 2013. View Article : Google Scholar : PubMed/NCBI
22	Ochi N, Matsuo Y, Sawai H, Yasuda A, Takahashi H, Sato M, Funahashi H, Okada Y and Manabe T: Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis. Pancreas. 34:444–451. 2007. View Article : Google Scholar : PubMed/NCBI
23	Wang CA, Harrell JC, Iwanaga R, Jedlicka P and Ford HL: Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3. Breast Cancer Res. 16:4622014. View Article : Google Scholar : PubMed/NCBI
24	Peng J, Shao N, Peng H and Chen LQ: Prognostic significance of vascular endothelial growth factor expession in esophageal carcinoma: A meta-analysis. J BUON. 18:398–406. 2013.PubMed/NCBI
25	Moon HE, Cheon H, Chun KH, Lee SK, Kim YS, Jung BK, Park JA, Kim SH, Jeong JW and Lee MS: Metastasis-associated protein 1 enhances angiogenesis by stabilization of HIF-1α. Oncol Rep. 16:929–935. 2006.PubMed/NCBI
26	Du B, Yang ZY, Zhong XY, Fang M, Yan YR, Qi GL, Pan YL and Zhou XL: Metastasis-associated protein 1 induces VEGF-C and facilitates lymphangiogenesis in colorectal cancer. World J Gastroenterol. 17:1219–1226. 2011. View Article : Google Scholar : PubMed/NCBI